查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598522

移植診斷市場：按產品、技術、移植、應用、最終用戶分類 - 2025-2030 年全球預測

Transplant Diagnostics Market by Offering (Instruments, Reagents & Consumables, Software & Services), Technology (Molecular Assays, Non-Molecular Assays), Transplant, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年移植診斷市值為45.9億美元，預計到2024年將達到49.1億美元，複合年成長率為7.55%，到2030年預計將達到76.5億美元。

移植診斷包括移植前適宜性評估、移植後監測和移植相關併發症診斷所需的各種測試和程序。這些診斷對於確定組織、器官和免疫相容性至關重要，從而提高移植成功率和患者預後。典型應用包括人類白血球抗原 (HLA) 分型、交叉配血和捐贈者特異性抗體評估。主要最終用戶包括醫院、移植中心和實驗室。導致器官衰竭的慢性疾病日益普及、分子診斷技術進步以及政府支持措施導致器官移植數量增加，推動了這一領域的成長。然而，市場擴張受到診斷程序相關的高成本和阻礙產品核可快速批准的嚴格監管要求的限制。器官捐贈者的缺乏加劇了這些挑戰。然而，自動化數位化，特別是次世代定序（NGS）技術和巨量資料分析，存在著巨大的機會來提高診斷的速度和準確性。公司可以利用人工智慧和機器學習的進步來改善預測分析和個人化診斷，從而提高患者照護和業務效率。為了利用這些機會，企業應注重策略夥伴關係和聯合研發，以創新低成本、高精度的解決方案。優先考慮新興國家的可及性也可能是有益的，這些國家的需求不斷成長，但資源可能有限。該市場的特點是穩步的技術創新，專注於提高診斷準確性和效率，並且在非侵入性檢測和即時監控解決方案方面取得突破的時機已經成熟。與監管機構的持續對話和簡化核准流程可能會緩解當前的限制，並為加速成長鋪平道路。總體而言，有效駕馭這個複雜的市場需要採取多方面的方法，將前沿研究、策略聯盟和對監管變化的敏捷響應結合起來。

主要市場統計
基準年[2023] 45.9億美元
預測年份 [2024] 49.1億美元
預測年份 [2030] 76.5億美元
複合年成長率（%） 7.55%

市場動態：快速發展的移植診斷市場的關鍵市場洞察

供需的動態交互作用正在改變移植診斷市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 器官捐贈意識增強，器官移植數量增加
    • 移植診斷藥物研發日益受到重視
    • 醫療旅遊在新興國家的擴張
  • 市場限制因素
    • 器官移植手術的高成本
  • 市場機會
    • 移植診斷技術不斷進步
    • 加強器官移植的監管指南
  • 市場挑戰
    • 缺乏保險/報銷政策和器官移植併發症

波特五力：駕馭移植診斷市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解移植診斷市場的外部影響

外部宏觀環境因素在塑造移植診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解移植診斷藥物市場的競爭狀況

對移植診斷市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣置入診斷市場供應商績效評估

FPNV定位矩陣是評估移植診斷市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪移植診斷市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，移植診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 器官捐贈意識增強，器官移植數量增加
      • 專注於移植診斷的研發
      • 醫療旅遊在新興國家的擴張
    • 抑制因素
      • 器官移植手術的高昂費用
    • 機會
      • 移植診斷技術不斷進步
      • 擴大器官移植的監管指南
    • 任務
      • 缺乏保險和報銷制度以及器官移植的併發症
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章移植診斷市場：透過提供

  • 裝置
  • 試劑/耗材
  • 軟體和服務

第7章移植診斷市場：依技術分類

  • 分子測定
  • 非分子測定

第8章移植診斷市場：依移植分類

  • 軟組織移植
  • 固態器官移植
  • 幹細胞移植

第9章移植診斷市場：依應用分類

  • 診斷應用
  • 調查申請

第 10 章 移植診斷市場：依最終使用者分類

  • 醫院及移植中心
  • 獨立參考實驗室
  • 研究實驗室和學術機構

第11章 北美和南美移植診斷藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太移植診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲移植診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Quest Diagnostics 宣佈在美國任何地方均可提供先進的移植診斷服務
    • Werfen 將以約 20 億美元收購輸血和移植診斷創新公司
    • Thermo Fisher 計劃以 26 億美元收購 Joint Site，以獲取專業的診斷產品組合。
    • Plexsion 在印度推出個人化移植診斷測試
    • Eurofins Viracor 在堪薩斯州萊內克薩開設大型研究實驗室
    • Immucoa 和 Pilche 宣佈建立多年合作夥伴關係
    • Eurofins Scientific SE：Transplant Genomics 宣布推出 Trugraf Liver，這是第一個也是唯一一個非侵入性基因表現表現診斷測試，旨在最佳化肝臟移植患者的免疫抑制
    • GenDx 根據與 Oxford Nanopore Technologies 的協議開發 NGS-Turbo
    • Eurobioscientific 以 1.35 億歐元收購荷蘭移植診斷公司 GenDx
    • Hologic 宣布 FDA核准Aptima CMV 定量檢測巨細胞病毒
    • Immucor 宣布移植診斷領域的創新
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Adaptive Biotechnologies Corporation
  • altona Diagnostics GmbH
  • Arquer Diagnostics Ltd.
  • BAG Group
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biogenuix Medsystems Pvt. Ltd
  • BioMerieux SA
  • Bruker Corporation
  • CareDx, Inc.
  • CLONIT srl
  • Diagnostica Longwood SL
  • DiaSorin SpA
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Genome Diagnostics BV
  • Hologic, Inc.
  • Illumina, Inc
  • Immucor, Inc.
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • Merck KGaA
  • NanoString Technologies, Inc.
  • Novartis AG
  • PathoNostics BV
  • QIAGEN, NV
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TransMedics, Inc.
  • Zimmer Biomet Group
Product Code: MRR-031685195790

The Transplant Diagnostics Market was valued at USD 4.59 billion in 2023, expected to reach USD 4.91 billion in 2024, and is projected to grow at a CAGR of 7.55%, to USD 7.65 billion by 2030.

Transplant diagnostics encompass a range of tests and procedures vital for pre-transplant compatibility assessments, post-transplant monitoring, and diagnosing transplant-related complications. These diagnostics are imperative in determining tissue, organ, and immune compatibility, thereby enhancing transplant success rates and patient outcomes. Key applications include Human Leukocyte Antigen (HLA) typing, cross-matching, and assessments of donor-specific antibodies. Major end-users comprise hospitals, transplant centers, and research laboratories. Growth in this sector is propelled by the increasing prevalence of chronic diseases leading to organ failure, technological advancements in molecular diagnostics, and a rising number of organ transplantations aided by supportive government initiatives. However, market expansion is restrained by high costs associated with diagnostic procedures and stringent regulatory requirements hampering swift product approvals. Furthermore, the scarcity of organ donors adds to these challenges. Nonetheless, tremendous opportunities exist in automation and digitalization, particularly within next-generation sequencing (NGS) technologies and big data analytics to improve diagnostic speed and precision. Companies can harness advancements in artificial intelligence and machine learning to refine predictive analytics and personalize diagnoses, thus enhancing patient care and operational efficiency. To capitalize on these opportunities, businesses should focus on strategic partnerships and collaborative R&D to innovate low-cost, high-accuracy solutions. Prioritizing accessibility in emerging economies, where demand is growing yet resources may be limited, will also prove beneficial. The market is characterized by steady innovation with a focus on improving diagnostic accuracy and efficiency, making it ripe for breakthroughs in non-invasive testing and real-time monitoring solutions. Engaging in continuous dialogue with regulatory bodies to streamline approval processes could mitigate current limitations, paving the way for accelerated growth. Overall, effective navigation of this complex market necessitates a multifaceted approach combining cutting-edge research, strategic alliances, and an agile adaptation to regulatory changes.

KEY MARKET STATISTICS
Base Year [2023] USD 4.59 billion
Estimated Year [2024] USD 4.91 billion
Forecast Year [2030] USD 7.65 billion
CAGR (%) 7.55%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transplant Diagnostics Market

The Transplant Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing awareness for organ donation and rise in organ transplant
    • Increased focus on research & development of transplant diagnostics
    • Growing medical tourism in developing countries
  • Market Restraints
    • High cost associated with organ transplant procedures
  • Market Opportunities
    • Increasing technological advancements in transplant diagnostics
    • Growing regulatory guidelines for organ transplant
  • Market Challenges
    • Lack of insurance and reimbursement policies and complications of organ transplant

Porter's Five Forces: A Strategic Tool for Navigating the Transplant Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transplant Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transplant Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transplant Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transplant Diagnostics Market

A detailed market share analysis in the Transplant Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transplant Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transplant Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transplant Diagnostics Market

A strategic analysis of the Transplant Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transplant Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaptive Biotechnologies Corporation, altona Diagnostics GmbH, Arquer Diagnostics Ltd., BAG Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biogenuix Medsystems Pvt. Ltd, BioMerieux SA, Bruker Corporation, CareDx, Inc., CLONIT srl, Diagnostica Longwood SL, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Genome Diagnostics B.V., Hologic, Inc., Illumina, Inc, Immucor, Inc., Laboratory Corporation of America Holdings, Luminex Corporation, Merck KGaA, NanoString Technologies, Inc., Novartis AG, PathoNostics B.V, QIAGEN, N.V., Quest Diagnostics Incorporated, Randox Laboratories Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., TransMedics, Inc., and Zimmer Biomet Group.

Market Segmentation & Coverage

This research report categorizes the Transplant Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Instruments, Reagents & Consumables, and Software & Services.
  • Based on Technology, market is studied across Molecular Assays and Non-Molecular Assays.
  • Based on Transplant, market is studied across Soft Tissue Transplant, Solid Organ Transplant, and Stem Cell Transplant.
  • Based on Application, market is studied across Diagnostic Applications and Research Applications.
  • Based on End User, market is studied across Hospitals & Transplant Centers, Independent Reference Laboratories, and Research Laboratories & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness for organ donation and rise in organ transplant
      • 5.1.1.2. Increased focus on research & development of transplant diagnostics
      • 5.1.1.3. Growing medical tourism in developing countries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with organ transplant procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing technological advancements in transplant diagnostics
      • 5.1.3.2. Growing regulatory guidelines for organ transplant
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of insurance and reimbursement policies and complications of organ transplant
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transplant Diagnostics Market, by Offering

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
  • 6.4. Software & Services

7. Transplant Diagnostics Market, by Technology

  • 7.1. Introduction
  • 7.2. Molecular Assays
  • 7.3. Non-Molecular Assays

8. Transplant Diagnostics Market, by Transplant

  • 8.1. Introduction
  • 8.2. Soft Tissue Transplant
  • 8.3. Solid Organ Transplant
  • 8.4. Stem Cell Transplant

9. Transplant Diagnostics Market, by Application

  • 9.1. Introduction
  • 9.2. Diagnostic Applications
  • 9.3. Research Applications

10. Transplant Diagnostics Market, by End User

  • 10.1. Introduction
  • 10.2. Hospitals & Transplant Centers
  • 10.3. Independent Reference Laboratories
  • 10.4. Research Laboratories & Academic Institutes

11. Americas Transplant Diagnostics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Transplant Diagnostics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Transplant Diagnostics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Quest Diagnostics unveils advanced transplant diagnostic services featuring anywhere-access in the United States
    • 14.3.2. Werfen to acquire transfusion and transplant diagnostics innovator for around USD 2 billion
    • 14.3.3. Thermo Fisher will buy the binding site for $2.6B to gain specialty diagnostics portfolio
    • 14.3.4. Plexision launches personalized transplant diagnostic testing in India
    • 14.3.5. Eurofins Viracor opens expansive laboratory in Lenexa, KS
    • 14.3.6. Immucor and Pirche announce multi-year partnership
    • 14.3.7. Eurofins Scientific SE: Transplant Genomics announces the launch of Trugraf Liver, the first and only non-invasive gene expression diagnostic test to optimize immunosuppression in liver transplant recipients
    • 14.3.8. GenDx to develop NGS-Turbo following agreement with Oxford Nanopore Technologies
    • 14.3.9. Eurobio Scientific buys Dutch transplant diagnostics firm GenDx for €135 million
    • 14.3.10. Hologic announces FDA approval of Aptima CMV Quant Assay For Human Cytomegalovirus
    • 14.3.11. Immucor announces innovations in transplant diagnostics
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Adaptive Biotechnologies Corporation
  • 3. altona Diagnostics GmbH
  • 4. Arquer Diagnostics Ltd.
  • 5. BAG Group
  • 6. Becton, Dickinson and Company
  • 7. Bio-Rad Laboratories, Inc.
  • 8. Biogenuix Medsystems Pvt. Ltd
  • 9. BioMerieux SA
  • 10. Bruker Corporation
  • 11. CareDx, Inc.
  • 12. CLONIT srl
  • 13. Diagnostica Longwood SL
  • 14. DiaSorin S.p.A.
  • 15. Eurofins Scientific SE
  • 16. F. Hoffmann-La Roche Ltd.
  • 17. Genome Diagnostics B.V.
  • 18. Hologic, Inc.
  • 19. Illumina, Inc
  • 20. Immucor, Inc.
  • 21. Laboratory Corporation of America Holdings
  • 22. Luminex Corporation
  • 23. Merck KGaA
  • 24. NanoString Technologies, Inc.
  • 25. Novartis AG
  • 26. PathoNostics B.V
  • 27. QIAGEN, N.V.
  • 28. Quest Diagnostics Incorporated
  • 29. Randox Laboratories Ltd.
  • 30. Takara Bio Inc.
  • 31. Thermo Fisher Scientific Inc.
  • 32. TransMedics, Inc.
  • 33. Zimmer Biomet Group

LIST OF FIGURES

  • FIGURE 1. TRANSPLANT DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSPLANT DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSPLANT DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NON-MOLECULAR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFT TISSUE TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOLID ORGAN TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STEM CELL TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS & TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023